MedTrace Logo

Fecal Calprotectin: Cheap Marker for Diagnosing Acute Infectious Diarrhea

NCT00429325 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2007-07-17

No results posted yet for this study

Summary

Every year more than 4 billion cases of diarrhea occur worldwide culminating in about 2.5 million deaths, almost all in the developing nations. Reliable diagnosis of patients with acute infectious diarrhea which could be appropriately managed with antibiotics at presentation still remains a formidable challenge to the clinicians. To address this issue of predicting microbiological infectious etiology for diagnosing acute infectious diarrhea, we would evaluate stools from all patients with acute diarrhea with culture, Guaiac based fecal occult blood test (FOBT), Calprotectin and lactoferrin assays simultaneously. This would be the first study evaluating fecal calprotectin as a diagnostic marker in acute diarrhea

Conditions

  • Acute Diarrhea

Sponsors & Collaborators

  • Johann Wolfgang Goethe University Hospital

    lead OTHER

Principal Investigators

  • Jürgen M Stein, MD,PhD · JW Goethe University Hospital, Frankfurt

  • Yogesh M Shastri, MD, DNB · JW Goethe University Hospital, Frankfurt

  • Wolfgang F Caspary, MD · JW Goethe University Hospital, Frankfurt

Eligibility

Min Age
18 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-01-31
Completion
2007-01-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00429325 on ClinicalTrials.gov